- The European Commission has signed a third contract with BioNTech SE BNTX and Pfizer Inc PFE for an additional 1.8 billion doses of its COVID-19 vaccine, Comirnaty.
- The contract reserves the doses on behalf of all European Union member states, between the end of 2021 to 2023, the statement added.
- The contract requires that the vaccine production is based in the EU and essential components are sourced from the EU.
- The new agreement will initially supply 900 million doses of the vaccine with an option to request up to an additional 900 million doses.
- The contract brings the total number of potential doses delivered to the EC, including all agreements, to up to 2.4 billion.
- Price Action: BNTX shares are down 1.04% at $197.01, and PFE shares are down 0.05% at $39.83 during the premarket session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
